THE ABILITY OF CONTRAST-ENHANCED ULTRASOUND IN THE DIAGNOSIS OF LIVER METASTASES IN CERVICAL CANCER
https://doi.org/10.17650/1994-4098-2017-13-4-44-49
Abstract
Objective: to explore the possibilities of contrast-enhanced ultrasound (CEUS) in the diagnosis of liver metastases in patients with a diagnosis of cervical cancer.
Materials and methods. We analyzed the results of 4 clinical cases, of which 3 cases according CEUS diagnosed with liver metastases, in 1 case – nodular hyperplasia.
Results and conclusions. Despite the small number of observations, we have concluded that the use of CEUS allows to expand possibilities of the ultrasound method in the differential diagnosis of focal changes in the liver.
About the Authors
V. S. Kryazheva
N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia
Russian Federation
23 Kashirskoe Shosse, Moscow 115478
Russian Federation
23 Kashirskoe Shosse, Moscow 115478
M. A. Chekalova
N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia
Russian Federation
23 Kashirskoe Shosse, Moscow 115478
Russian Federation
23 Kashirskoe Shosse, Moscow 115478
Z. R-B. Musaeva
N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia
Russian Federation
23 Kashirskoe Shosse, Moscow 115478
Russian Federation
23 Kashirskoe Shosse, Moscow 115478
V. V. Kuznetsov
N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia
Russian Federation
23 Kashirskoe Shosse, Moscow 115478
Russian Federation
23 Kashirskoe Shosse, Moscow 115478
References
1. Клиническая онкогинекология. Под ред. В.П. Козаченко. М.: Бином, 2016. С. 137–139. [Clinical gynecologic oncology. Ed. by V.P. Kozachenko. Moscow: Binom, 2016. Pp. 137–139. (In Russ.)].
2. Zola P., Fuso L., Mazzola S. et al. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Gynecol Oncol 2007;107(1 Suppl):S150–4. DOI: 10.1016/j.ygyno.2007.07.028.
3. Bacalbasa N., Balescu I., Dima S., Popescu I. Hepatic resection for liver metastases from cervical cancer is safe and may have survival benefit. Anticancer Res 2016;36(6):3023–7. PMID: 27272821.
4. Калабанова Е.А., Неродо Г .А., Гусько- ва Е.А., Розенко Л.Я. К вопросу о метастазировании и рецидивировании при раке шейки матки. Сибирский онкологический журнал 2009;1;87–8. [Kalabanova E.A., Nerodo G.A., Gusko- va E.A., Rozenko L.Ya. Metastasis and recurrence in cervical cancer. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2009;1;87–8. (In Russ.)].
5. Рубцова Н.А., Новикова Е.Г., Сини- цын В.Е. Роль диффузно-взвешенной магнитно-резонансной томографии в диагностике рецидивных опухолей матки. Радиология – практика 2012;4;42. [Rubtsova N.A., Novikova E.G., Sinitsyn V.E. The role of diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent tumors of the uterus. Radiologiya – praktika = Radiology – practice 2012;4;42. (In Russ.)].
6. Greus C. Technology overview: SonoVue (Bracco, Milan). Eur Radiol 2004;(14 Suppl 8):420–30. PMID: 15700328.
7. Albrecht T., Blomley M., Bolondi L. et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 2004;25(4):249-56. DOI: 10.1055/s-2004-813245.
8. Bernatik T., Seitz K., Blank W. et al. Unclear focal liver lesions in contrastenhanced ultrasonography – lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors. Ultraschall Med 2010;31(6):577–81. DOI: 10.1055/s-0029-1245649.
9. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver – update 2012. Available at: https://www.thiemeconnect.de/products/ejournals/html/10.1055/s-0032-1325499#N67296
10. Dietrich C.F., Kratzer W., Strobe D. et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006;12 (11):1699–705. PMID: 16586537.
11. Piscaglia F., Venturi A., Mancini M. et al. Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver. Ultraschall Med 2010;31(3):276–82. PMID: 19941252. DOI: 10.1055/s-0028-1109852.
12. Yen Y.H., Wang J.H., Lu S.N. et al. Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia. Eur J Radiol 2006;60(3): 439–44. PMID: 16916591. DOI: http://dx.doi.org/10.1016/j.ejrad.2006.06.007.
13. Dong Y., Wang W.P., Cantisani V. et al. Contrast-enhanced ultrasound of histologically proven hepatic epithelioid hemangioendothelioma. World J Gastroenterol 2016;22(19):4741–9. PMID: 27217705. DOI: 10.3748/wjg.v22.i19.4741.
14. Weskott H.P. Contrast sonography. 2nd edn. Bremen: Uni-Med, 2014. Pp. 20–23.
Review
For citations:
Kryazheva V.S., Chekalova M.A., Musaeva Z.R., Kuznetsov V.V. THE ABILITY OF CONTRAST-ENHANCED ULTRASOUND IN THE DIAGNOSIS OF LIVER METASTASES IN CERVICAL CANCER. Tumors of female reproductive system. 2017;13(4):44-49. (In Russ.) https://doi.org/10.17650/1994-4098-2017-13-4-44-49
Views:
721
Email this article 